Deepu S Nair, MD
Cardiovascular Disease (Cardiology) · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 3 carriers
- Offices
- 15
Offices
15 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
3 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nair’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A82854 · Current
Licensed to practise in California · since 2003 · expires 2028-06-30 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$376,169
Medicare paid this office $376,169 for 1,758 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 596 | $105,218 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 276 | $53,581 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 98 | $28,871 | $103 |
| Long return visit (40+ min) | 102 | $19,601 | $162 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 94 | $18,425 | $196 |
See all 38 services
| Return visit (30+ min) | 596 | $105,218 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 276 | $53,581 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 98 | $28,871 | $103 |
| Long return visit (40+ min) | 102 | $19,601 | $162 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 94 | $18,425 | $196 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 16 | $16,065 | $1,004 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $12,579 | $148 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 195 | $12,008 | $59 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 50 | $11,336 | $227 |
| Ct scan of blood vessels and grafts of heart with contrast | 37 | $10,900 | $295 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 447 | $7,862 | $15 |
| Critical care, first 30-74 minutes | 14 | $7,412 | $185 |
| New patient visit (45+ min) | 47 | $6,689 | $142 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 13 | $5,930 | $456 |
| Ultrasound of heart with probe in esophagus, with report | 63 | $5,815 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 408 | $5,583 | $13 |
| New patient visit (60+ min) | 22 | $4,419 | $201 |
| Programming of dual lead pacemaker system | 45 | $4,078 | $68 |
| Hospital discharge day management, more than 30 minutes | 35 | $3,672 | $105 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 67 | $3,515 | $22 |
| Short return visit (20+ min) | 43 | $3,478 | $77 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 57 | $3,327 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 117 | $2,531 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 27 | $1,695 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 177 | $1,535 | $7 |
| Heart rhythm recording of continous external ekg over 8-15 days | 118 | $1,488 | $12 |
| 3d radiographic procedure with computerized image postprocessing | 38 | $1,277 | $34 |
| Ultrasound of heart blood flow, valves and chambers | 63 | $1,002 | $16 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 21 | $877 | $42 |
| Ultrasound of heart, follow-up | 30 | $734 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 14 | $655 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $472 | $36 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 37 | $415 | $0 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 18 | $351 | $18 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 18 | $225 | $12 |
| Ultrasonic guidance for blood vessel access | 16 | $191 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $147 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $86 | $3 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
1,758 Original Medicare patients in 2024. Average age 78 · Under 65 2% · 85 and older 23% · Women 51% · Also on Medicaid 13% · Health risk score 1.39. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 42% · Atrial fibrillation 36% · Diabetes 31% · Chronic kidney disease 30% · Heart failure 27% · Depression 18% · Cancer 17% · COPD 13% · Stroke 11% · Dementia 10%.
The office billed $1,658,855, Medicare allowed $504,778 and paid $376,169; for 8,608 services of 66 kinds; $545 of it was for drugs given in the office and $375,623 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,758 | 8,608 | 78 | 1.39 | $1,658,855 | $376,169 |
| 2023 | 1,712 | 6,363 | 78 | 1.33 | $1,389,052 | $343,918 |
| 2022 | 1,884 | 6,638 | 78 | 1.38 | $1,472,507 | $371,958 |
| 2021 | 1,981 | 8,986 | 78 | 1.34 | $1,603,080 | $387,962 |
| 2020 | 1,761 | 5,608 | 77 | 1.44 | $1,339,176 | $331,167 |
| 2019 | 2,147 | 4,548 | 77 | 1.38 | $1,372,274 | $335,782 |
| 2018 | 1,980 | 4,235 | 77 | 1.44 | $1,199,345 | $299,549 |
| 2017 | 1,777 | 4,110 | 77 | 1.48 | $1,212,055 | $316,203 |
| 2016 | 1,917 | 4,000 | 77 | 1.45 | $1,087,318 | $285,047 |
| 2015 | 1,724 | 3,684 | 77 | 1.41 | $1,056,314 | $286,850 |
| 2014 | 1,369 | 3,092 | 76 | 1.24 | $995,646 | $260,016 |
| 2013 | 1,404 | 2,981 | 77 | 1.38 | $892,878 | $223,472 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 39 services
| Return visit (30+ min) | 555 | $101,995 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 193 | $37,741 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $23,840 | $109 |
| Long return visit (40+ min) | 86 | $17,587 | $164 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 61 | $14,481 | $237 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 222 | $14,227 | $62 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 11 | $12,396 | $1,127 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $11,945 | $478 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 58 | $11,647 | $201 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $11,515 | $156 |
| Ct scan of blood vessels and grafts of heart with contrast | 33 | $9,739 | $295 |
| New patient visit (45+ min) | 60 | $8,881 | $148 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 430 | $5,756 | $13 |
| Short return visit (20+ min) | 65 | $5,610 | $81 |
| New patient visit (60+ min) | 28 | $5,387 | $192 |
| Ultrasound of heart with probe in esophagus, with report | 55 | $5,340 | $97 |
| Critical care, first 30-74 minutes | 15 | $5,193 | $192 |
| Programming of dual lead pacemaker system | 47 | $4,817 | $80 |
| Injection, regadenoson, 0.1 mg | 21 | $4,076 | None |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 25 | $3,811 | $76 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 42 | $2,813 | $67 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 104 | $2,440 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 58 | $1,828 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 51 | $1,689 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 180 | $1,543 | $7 |
| Heart rhythm recording of continous external ekg over 8-15 days | 104 | $1,372 | $13 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,178 | $107 |
| Programming of single lead pacemaker system | 12 | $929 | $66 |
| Ultrasound of heart blood flow, valves and chambers | 56 | $920 | $16 |
| 3d radiographic procedure with computerized image postprocessing | 20 | $703 | $35 |
| 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | 22 | $482 | $22 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 23 | $477 | $21 |
| Ultrasound of heart, follow-up | 17 | $367 | $22 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 32 | $306 | $0 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 23 | $297 | $13 |
| Electrocardiogram (ecg) 2-day continuous | 12 | $229 | $19 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $200 | $17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $165 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $49 | $3 |
2022: 43 services
| Return visit (30+ min) | 588 | $110,069 | $113 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 286 | $60,154 | $198 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 18 | $19,396 | $1,078 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 82 | $16,983 | $205 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 34 | $16,165 | $475 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $13,736 | $93 |
| Long return visit (40+ min) | 72 | $13,301 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 174 | $11,389 | $63 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 43 | $9,605 | $223 |
| Ct scan of blood vessels and grafts of heart with contrast | 28 | $8,439 | $301 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,441 | $177 |
| Ultrasound of heart with probe in esophagus, with report | 69 | $6,975 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 463 | $6,138 | $13 |
| New patient visit (45+ min) | 43 | $6,063 | $141 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 32 | $5,710 | $89 |
| Injection, regadenoson, 0.1 mg | 29 | $5,624 | None |
| Short return visit (20+ min) | 59 | $5,087 | $82 |
| Critical care, first 30-74 minutes | 13 | $4,732 | $197 |
| Programming of dual lead pacemaker system | 42 | $4,527 | $77 |
| New patient visit (60+ min) | 20 | $3,918 | $196 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $3,343 | $257 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 56 | $3,280 | $59 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 127 | $3,067 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 322 | $2,881 | $7 |
| Heart rhythm recording of continous external ekg over 8-15 days | 127 | $1,946 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 46 | $1,496 | $23 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,475 | $98 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 40 | $1,239 | $24 |
| Programming of single lead pacemaker system | 17 | $1,186 | $66 |
| Ultrasound of heart blood flow, valves and chambers | 70 | $1,186 | $16 |
| Ct scan of heart with evaluation of blood vessel calcium | 11 | $1,032 | $94 |
| 3d radiographic procedure with computerized image postprocessing | 21 | $751 | $36 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $673 | $61 |
| Ultrasound of heart, follow-up | 25 | $581 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 51 | $570 | $11 |
| 3d radiographic procedure | 33 | $294 | $9 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 13 | $287 | $22 |
| Electrocardiogram (ecg) 2-day continuous | 13 | $276 | $21 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $226 | $17 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 28 | $224 | $0 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 13 | $206 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 70 | $206 | $3 |
| Ultrasonic guidance for blood vessel access | 11 | $137 | $12 |
2021: 36 services
| Return visit (30+ min) | 553 | $101,178 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $50,124 | $205 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $22,736 | $505 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $20,661 | $95 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 87 | $18,514 | $210 |
| Long return visit (40+ min) | 92 | $17,014 | $159 |
| Ct scan of blood vessels and grafts of heart with contrast | 54 | $16,353 | $303 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $15,905 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $15,293 | $180 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 49 | $12,133 | $248 |
| New patient visit (45+ min) | 68 | $10,152 | $149 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 589 | $8,431 | $14 |
| Ultrasound of heart with probe in esophagus, with report | 75 | $7,558 | $97 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 41 | $7,126 | $88 |
| New patient visit (60+ min) | 32 | $6,665 | $208 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 35 | $5,954 | $170 |
| Injection, regadenoson, 0.1 mg | 33 | $5,344 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 67 | $4,139 | $62 |
| Programming of dual lead pacemaker system | 36 | $4,085 | $80 |
| Short return visit (20+ min) | 41 | $3,722 | $79 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $3,127 | $261 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 293 | $2,891 | $8 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 119 | $2,885 | $23 |
| Hospital discharge day management, more than 30 minutes | 26 | $2,595 | $100 |
| Heart rhythm recording of continous external ekg over 8-15 days | 119 | $1,910 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 46 | $1,686 | $26 |
| Programming of single lead pacemaker system | 15 | $1,549 | $67 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 39 | $1,248 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 71 | $1,182 | $16 |
| External shock to heart to regulate heart beat | 12 | $1,103 | $92 |
| Ultrasound of heart, follow-up | 40 | $943 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 63 | $721 | $11 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 53 | $428 | $0 |
| Electrocardiogram (ecg) 2-day continuous | 21 | $418 | $20 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 21 | $334 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 73 | $214 | $3 |
2020: 39 services
| Return visit (30+ min) | 431 | $67,991 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 233 | $50,267 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $25,964 | $96 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 46 | $23,791 | $517 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 200 | $14,292 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $14,174 | $182 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 54 | $11,627 | $215 |
| Long return visit (40+ min) | 82 | $11,256 | $131 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 577 | $9,229 | $15 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 43 | $9,168 | $213 |
| New patient visit (45+ min) | 59 | $8,512 | $144 |
| Injection, regadenoson, 0.1 mg | 37 | $6,972 | None |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 38 | $6,829 | $90 |
| Ultrasound of heart with probe in esophagus, with report | 61 | $6,374 | $101 |
| Telephone medical discussion with physician, 21-30 minutes | 52 | $5,719 | $102 |
| Ct scan of blood vessels and grafts of heart with contrast | 18 | $5,665 | $315 |
| Short return visit (20+ min) | 71 | $4,722 | $62 |
| Critical care, first 30-74 minutes | 12 | $4,408 | $200 |
| External ekg recording for more than 48 hours up to 21 days | 137 | $3,799 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 63 | $3,731 | $59 |
| Telephone medical discussion with physician, 11-20 minutes | 49 | $3,471 | $68 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 137 | $3,366 | $24 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $2,934 | $267 |
| Programming of dual lead pacemaker system | 32 | $2,721 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 208 | $2,032 | $8 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,967 | $98 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 52 | $1,694 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 41 | $1,282 | $24 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 23 | $1,101 | $48 |
| Ultrasound of heart blood flow, valves and chambers | 59 | $1,062 | $17 |
| Programming of single lead pacemaker system | 13 | $965 | $48 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 60 | $729 | $11 |
| Electrocardiogram (ecg) 2-day continuous | 24 | $627 | $26 |
| Injection of drug or substance into vein | 14 | $589 | $42 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 24 | $571 | $24 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 14 | $515 | $26 |
| Ultrasound of heart, follow-up | 15 | $411 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 59 | $185 | $3 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13 | $87 | $0 |
2019: 37 services
| Return visit (30+ min) | 475 | $74,831 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 230 | $48,631 | $205 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 52 | $26,733 | $514 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $20,893 | $94 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 63 | $13,881 | $220 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 200 | $13,475 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 803 | $12,881 | $15 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $12,560 | $179 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 53 | $11,344 | $210 |
| New patient visit (45+ min) | 71 | $10,362 | $146 |
| Long return visit (40+ min) | 58 | $9,038 | $133 |
| Short return visit (20+ min) | 108 | $8,276 | $66 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 44 | $7,551 | $88 |
| Injection, regadenoson, 0.1 mg | 37 | $6,574 | None |
| Ultrasound of heart with probe in esophagus, with report | 59 | $6,340 | $98 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $6,123 | $245 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 89 | $5,631 | $63 |
| Programming of dual lead pacemaker system | 47 | $4,573 | $59 |
| Critical care, first 30-74 minutes | 16 | $3,880 | $194 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 324 | $2,972 | $8 |
| External ekg recording for more than 48 hours up to 21 days | 104 | $2,698 | $25 |
| Hospital discharge day management, more than 30 minutes | 26 | $2,688 | $100 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 104 | $2,431 | $23 |
| New patient visit (60+ min) | 13 | $2,234 | $172 |
| Injection of drug or substance into vein | 32 | $1,309 | $41 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,259 | $66 |
| Ultrasound of heart blood flow, valves and chambers | 59 | $1,072 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 82 | $979 | $11 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 26 | $971 | $26 |
| Programming of single lead pacemaker system | 12 | $945 | $50 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $923 | $40 |
| Electrocardiogram (ecg) 2-day continuous | 35 | $866 | $25 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 35 | $773 | $22 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 14 | $643 | $46 |
| Ultrasound of heart, follow-up | 19 | $451 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 13 | $337 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 59 | $187 | $3 |
2018: 31 services
| Return visit (30+ min) | 443 | $73,306 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 229 | $48,875 | $203 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 42 | $21,498 | $512 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $16,349 | $93 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 54 | $12,308 | $228 |
| Short return visit (20+ min) | 135 | $10,614 | $62 |
| New patient visit (45+ min) | 75 | $10,603 | $141 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 725 | $10,338 | $14 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 48 | $10,227 | $201 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $9,531 | $177 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 135 | $9,191 | $64 |
| Ultrasound of heart with probe in esophagus, with report | 71 | $7,293 | $96 |
| Long return visit (40+ min) | 38 | $5,322 | $130 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 30 | $4,878 | $87 |
| Injection, regadenoson, 0.1 mg | 26 | $4,610 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 78 | $4,536 | $58 |
| Programming of dual lead pacemaker system | 50 | $4,149 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 344 | $3,188 | $8 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $2,684 | $244 |
| External ekg recording for more than 48 hours up to 21 days | 99 | $2,505 | $25 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 13 | $2,293 | $96 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 98 | $2,240 | $22 |
| Hospital discharge day management, more than 30 minutes | 22 | $2,173 | $99 |
| Ultrasound of heart blood flow, valves and chambers | 69 | $1,202 | $16 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $999 | $48 |
| Electrocardiogram (ecg) 2-day continuous | 39 | $969 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 78 | $893 | $11 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 38 | $883 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 17 | $696 | $25 |
| Ultrasound of heart, follow-up | 26 | $606 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 70 | $212 | $3 |
2017: 32 services
| Return visit (30+ min) | 452 | $82,285 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 239 | $56,776 | $222 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 57 | $28,190 | $486 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 61 | $15,873 | $260 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $11,448 | $93 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 58 | $11,164 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 166 | $9,329 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 605 | $9,196 | $15 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 43 | $8,735 | $199 |
| New patient visit (45+ min) | 59 | $7,843 | $133 |
| Long return visit (40+ min) | 58 | $7,554 | $124 |
| Short return visit (20+ min) | 114 | $7,292 | $57 |
| Injection, regadenoson, 0.1 mg | 40 | $6,725 | None |
| Ultrasound of heart with probe in esophagus, with report | 58 | $6,384 | $94 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 88 | $5,468 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,439 | $181 |
| Programming of dual lead pacemaker system | 45 | $3,774 | $49 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,577 | $238 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,989 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 278 | $2,550 | $8 |
| External ekg recording for more than 48 hours up to 21 days | 76 | $2,259 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 76 | $1,958 | $24 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,816 | $114 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,627 | $96 |
| Electrocardiogram (ecg) 2-day continuous | 43 | $1,172 | $25 |
| Ultrasound of heart blood flow, valves and chambers | 57 | $1,073 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 43 | $1,039 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 52 | $709 | $11 |
| Ultrasound of heart, follow-up | 23 | $558 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 11 | $306 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 62 | $195 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $73 | $6 |
2016: 29 services
| Return visit (30+ min) | 370 | $64,765 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 250 | $57,111 | $221 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 44 | $21,937 | $499 |
| Short return visit (20+ min) | 240 | $16,829 | $56 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 49 | $13,054 | $266 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 166 | $9,717 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 618 | $9,117 | $14 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 44 | $8,266 | $94 |
| New patient visit (45+ min) | 52 | $7,312 | $141 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 35 | $7,031 | $201 |
| Ultrasound of heart with probe in esophagus, with report | 49 | $6,519 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $5,648 | $93 |
| Injection, regadenoson, 0.1 mg | 32 | $5,400 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,657 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $4,565 | $62 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 68 | $4,560 | $64 |
| Programming of dual lead pacemaker system | 49 | $4,301 | $49 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $4,104 | $257 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 451 | $3,871 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,978 | $119 |
| Long return visit (40+ min) | 22 | $2,932 | $133 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,877 | $94 |
| External ekg recording for more than 48 hours up to 21 days | 62 | $1,658 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 60 | $1,398 | $23 |
| Electrocardiogram (ecg) 2-day continuous | 41 | $1,121 | $27 |
| Ultrasound of heart blood flow, valves and chambers | 49 | $1,004 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 41 | $993 | $24 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $837 | $33 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 50 | $195 | $3 |
2015: 31 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 225 | $55,167 | $236 |
| Return visit (30+ min) | 286 | $52,033 | $98 |
| Short return visit (20+ min) | 293 | $27,979 | $64 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 53 | $27,465 | $518 |
| New patient visit (45+ min) | 95 | $14,526 | $153 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 54 | $14,282 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 645 | $10,460 | $16 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 35 | $9,866 | $282 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $7,437 | $58 |
| Injection, regadenoson, 0.1 mg | 40 | $6,625 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $6,313 | $67 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 87 | $5,832 | $67 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 25 | $5,272 | $211 |
| Ultrasound of heart with probe in esophagus, with report | 40 | $4,746 | $110 |
| Programming of dual lead pacemaker system | 43 | $3,751 | $51 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,041 | $190 |
| New patient visit (30+ min) | 26 | $2,490 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 262 | $2,458 | $8 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,343 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $2,049 | $128 |
| Long return visit (40+ min) | 12 | $1,702 | $142 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,641 | $97 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $1,535 | $35 |
| Electrocardiogram (ecg) 2-day continuous | 51 | $1,449 | $28 |
| External ekg recording for more than 48 hours up to 21 days | 45 | $1,331 | $30 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 51 | $1,256 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 47 | $1,190 | $25 |
| Programming of single lead pacemaker system | 15 | $1,047 | $44 |
| Ultrasound of heart blood flow, valves and chambers | 39 | $726 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 39 | $136 | $3 |
| Injection, aminophyllin, up to 250 mg | 11 | $9 | None |
2014: 29 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 210 | $47,055 | $223 |
| Return visit (30+ min) | 238 | $42,353 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 57 | $27,459 | $482 |
| Short return visit (20+ min) | 246 | $21,994 | $61 |
| New patient visit (45+ min) | 111 | $15,634 | $141 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 57 | $15,029 | $132 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 45 | $12,247 | $272 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 652 | $9,714 | $14 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 27 | $6,793 | $243 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 112 | $6,073 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $6,031 | $62 |
| Injection, regadenoson, 0.1 mg | 34 | $5,530 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,677 | $180 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 75 | $4,579 | $61 |
| Ultrasound of heart with probe in esophagus, with report | 38 | $4,222 | $92 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $3,237 | $270 |
| Programming of dual lead pacemaker system | 34 | $3,098 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,050 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,442 | $116 |
| Long return visit (40+ min) | 16 | $2,003 | $125 |
| External shock to heart to regulate heart beat | 15 | $1,768 | $110 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,641 | $97 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 25 | $1,614 | $32 |
| New patient visit (30+ min) | 19 | $1,589 | $84 |
| Electrocardiogram (ecg) 2-day continuous | 49 | $1,226 | $25 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 50 | $1,096 | $22 |
| Programming of single lead pacemaker system | 13 | $926 | $44 |
| Ultrasound of heart blood flow, valves and chambers | 36 | $713 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 39 | $138 | $3 |
2013: 27 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 201 | $38,608 | $182 |
| Return visit (30+ min) | 209 | $38,162 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 57 | $28,213 | $495 |
| Short return visit (20+ min) | 226 | $20,150 | $61 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 55 | $14,052 | $133 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 620 | $10,627 | $17 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 39 | $8,357 | $214 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 114 | $6,369 | $53 |
| New patient visit (45+ min) | 44 | $6,338 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $6,311 | $62 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 83 | $4,908 | $59 |
| Injection, regadenoson, 0.1 mg | 30 | $4,567 | None |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,729 | $110 |
| Long return visit (40+ min) | 28 | $3,659 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,428 | $163 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $3,380 | $241 |
| Programming of dual lead pacemaker system | 28 | $2,494 | $49 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $2,349 | $90 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 32 | $2,155 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 146 | $1,309 | $7 |
| Electrocardiogram (ecg) 2-day continuous | 37 | $1,017 | $27 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 37 | $863 | $23 |
| Programming of single lead pacemaker system | 11 | $716 | $40 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $418 | $16 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 11 | $237 | $22 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 11 | $105 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $90 | $3 |
Medicaid work
$1,735 in 2024
Medicaid paid $1,735 for 210 billed services this clinician did in 2024, up to 120 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 48 | $786 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 131 | $503 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 31 | $447 |
| 2024 | 210 | 3 | 120 | $1,735 |
| 2023 | 341 | 4 | 56 | $4,933 |
| 2022 | 362 | 3 | 101 | $3,045 |
| 2021 | 399 | 4 | 82 | $3,524 |
| 2020 | 261 | 4 | 64 | $3,329 |
| 2019 | 378 | 4 | 54 | $6,941 |
| 2018 | 266 | 3 | 58 | $3,079 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 41 | $2,400 |
| Return visit (30+ min) | 132 | $1,353 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 126 | $609 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 42 | $571 |
2022
| Return visit (30+ min) | 138 | $1,557 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 196 | $1,028 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 28 | $459 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 75 | $1,135 |
| Return visit (30+ min) | 124 | $1,068 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 186 | $755 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $566 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 15 | $1,603 |
| Return visit (30+ min) | 95 | $770 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 126 | $644 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 25 | $312 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 27 | $2,538 |
| Return visit (30+ min) | 110 | $2,128 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 95 | $1,639 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 146 | $636 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 76 | $1,583 |
| Return visit (30+ min) | 49 | $855 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 141 | $641 |
Drugs they prescribed that Part D paid
$1,612,932
Pharmacies billed $1,612,932 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 6,287) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
5,211 generic and 1,076 brand-name prescriptions · $1,612,932 in drug cost · 13 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 545 | $812,845 | $1,491 |
| Repatha Sureclick | 137 | $169,565 | $1,238 |
| Entresto | 103 | $163,094 | $1,583 |
| Jardiance | 98 | $146,826 | $1,498 |
| Xarelto | 51 | $78,487 | $1,539 |
See all 52 drugs
| Eliquis | 545 | $812,845 | $1,491 |
| Repatha Sureclick | 137 | $169,565 | $1,238 |
| Entresto | 103 | $163,094 | $1,583 |
| Jardiance | 98 | $146,826 | $1,498 |
| Xarelto | 51 | $78,487 | $1,539 |
| Praluent | 27 | $23,382 | $866 |
| Farxiga | 20 | $22,372 | $1,119 |
| Vascepa | 17 | $15,835 | $931 |
| Metoprolol | 590 | $10,076 | $17 |
| Rosuvastatin | 571 | $9,688 | $17 |
| Ezetimibe | 329 | $9,302 | $28 |
| Atorvastatin | 706 | $7,222 | $10 |
| Diltiazem 24hr Er (Cd) | 176 | $6,184 | $35 |
| Bumetanide | 91 | $4,341 | $48 |
| Losartan | 361 | $3,742 | $10 |
| Amlodipine Besylate | 405 | $3,051 | $8 |
| Flecainide Acetate | 44 | $2,572 | $58 |
| Carvedilol | 181 | $2,534 | $14 |
| Digoxin | 86 | $1,919 | $22 |
| Valsartan | 55 | $1,905 | $35 |
| Furosemide | 211 | $1,813 | $9 |
| Clopidogrel | 103 | $1,778 | $17 |
| Potassium Chloride | 91 | $1,627 | $18 |
| Lisinopril | 165 | $1,438 | $9 |
| Isosorbide Dinitrate | 17 | $1,362 | $80 |
| Isosorbide Mononitrate Er | 66 | $1,322 | $20 |
| Ranolazine Er | 11 | $1,300 | $118 |
| Doxazosin Mesylate | 65 | $1,106 | $17 |
| Pravastatin | 49 | $1,043 | $21 |
| Metoprolol | 146 | $1,002 | $7 |
| Dilt-Xr | 12 | $952 | $79 |
| Pantoprazole | 47 | $789 | $17 |
| Amiodarone | 31 | $741 | $24 |
| Hydralazine | 52 | $677 | $13 |
| Nifedipine Er | 15 | $617 | $41 |
| Cartia Xt | 18 | $542 | $30 |
| Verapamil Er | 14 | $534 | $38 |
| Spironolactone | 64 | $395 | $6 |
| Nitroglycerin | 45 | $369 | $8 |
| Hydrochlorothiazide | 72 | $365 | $5 |
| Benazepril | 30 | $349 | $12 |
| Olmesartan Medoxomil | 13 | $341 | $26 |
| Losartan-Hydrochlorothiazide | 16 | $292 | $18 |
| Atenolol | 29 | $261 | $9 |
| Torsemide | 15 | $257 | $17 |
| Triamterene-Hydrochlorothiazid | 15 | $252 | $17 |
| Omeprazole | 18 | $212 | $12 |
| Bisoprolol | 13 | $172 | $13 |
| Simvastatin | 24 | $151 | $6 |
| Warfarin | 12 | $88 | $7 |
| Ramipril | 11 | $45 | $4 |
| Amoxicillin | 13 | $34 | $3 |
Year by year
| 2024 | 6,287 | 798 | 0% (0) | 17% | $1,612,932 |
| 2023 | 5,835 | 737 | 0% (0) | None | $1,466,615 |
| 2022 | 5,596 | 691 | None | 15% | $1,338,210 |
| 2021 | 5,437 | 683 | 0% (0) | 16% | $1,111,805 |
| 2020 | 4,888 | 626 | 0% (0) | 17% | $802,789 |
| 2019 | 4,195 | 552 | None | 19% | $691,973 |
| 2018 | 3,755 | 488 | 0% (0) | 21% | $567,001 |
| 2017 | 3,380 | 449 | 0% (0) | None | $434,254 |
| 2016 | 2,972 | 409 | 0% (0) | 24% | $322,565 |
| 2015 | 2,617 | 406 | 0% (0) | 21% | $221,896 |
| 2014 | 2,371 | 338 | None | 21% | $168,360 |
| 2013 | 2,020 | 287 | None | 23% | $128,563 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 50 drugs
| Eliquis | 488 | $741,535 | $1,520 |
| Repatha Sureclick | 114 | $146,096 | $1,282 |
| Entresto | 84 | $134,653 | $1,603 |
| Jardiance | 46 | $79,617 | $1,731 |
| Xarelto | 46 | $70,868 | $1,541 |
| Praluent | 26 | $32,996 | $1,269 |
| Ezetimibe | 243 | $14,719 | $61 |
| Rosuvastatin | 459 | $11,936 | $26 |
| Farxiga | 13 | $11,168 | $859 |
| Metoprolol | 520 | $10,584 | $20 |
| Diltiazem 24hr Er (Cd) | 162 | $8,747 | $54 |
| Atorvastatin | 626 | $7,669 | $12 |
| Bumetanide | 94 | $6,879 | $73 |
| Losartan | 327 | $5,416 | $17 |
| Amlodipine Besylate | 398 | $4,675 | $12 |
| Carvedilol | 207 | $3,842 | $19 |
| Flecainide Acetate | 53 | $3,299 | $62 |
| Valsartan | 61 | $3,225 | $53 |
| Digoxin | 102 | $3,220 | $32 |
| Potassium Chloride | 94 | $2,697 | $29 |
| Isosorbide Mononitrate Er | 73 | $2,682 | $37 |
| Furosemide | 262 | $2,548 | $10 |
| Isosorbide Dinitrate | 20 | $2,050 | $103 |
| Metoprolol | 149 | $1,897 | $13 |
| Lisinopril | 165 | $1,726 | $10 |
| Clopidogrel | 81 | $1,699 | $21 |
| Doxazosin Mesylate | 61 | $1,534 | $25 |
| Diltiazem 24hr Er (Xr) | 18 | $1,109 | $62 |
| Pantoprazole | 52 | $1,027 | $20 |
| Nitroglycerin | 48 | $828 | $17 |
| Hydralazine | 47 | $827 | $18 |
| Cartia Xt | 14 | $826 | $59 |
| Amiodarone | 23 | $772 | $34 |
| Olmesartan Medoxomil | 15 | $744 | $50 |
| Pravastatin | 42 | $738 | $18 |
| Atenolol | 42 | $686 | $16 |
| Benazepril | 33 | $666 | $20 |
| Hydrochlorothiazide | 70 | $621 | $9 |
| Verapamil Er | 12 | $573 | $48 |
| Diltiazem 24hr Er | 18 | $532 | $30 |
| Spironolactone | 52 | $527 | $10 |
| Losartan-Hydrochlorothiazide | 19 | $419 | $22 |
| Nifedipine Er | 12 | $366 | $31 |
| Simvastatin | 33 | $312 | $9 |
| Omeprazole | 20 | $286 | $14 |
| Enalapril Maleate | 11 | $257 | $23 |
| Warfarin | 13 | $248 | $19 |
| Triamterene-Hydrochlorothiazid | 14 | $216 | $15 |
| Clonidine | 15 | $201 | $13 |
| Amoxicillin | 17 | $31 | $2 |
2022: 45 drugs
| Eliquis | 475 | $683,686 | $1,439 |
| Repatha Sureclick | 106 | $107,186 | $1,011 |
| Xarelto | 62 | $82,069 | $1,324 |
| Entresto | 43 | $74,983 | $1,744 |
| Ezetimibe | 158 | $13,399 | $85 |
| Rosuvastatin | 364 | $12,207 | $34 |
| Metoprolol | 519 | $11,910 | $23 |
| Bumetanide | 74 | $10,036 | $136 |
| Diltiazem 24hr Er (Cd) | 171 | $8,673 | $51 |
| Atorvastatin | 658 | $7,601 | $12 |
| Valsartan | 66 | $5,845 | $89 |
| Digoxin | 110 | $4,928 | $45 |
| Carvedilol | 219 | $3,968 | $18 |
| Losartan | 309 | $3,929 | $13 |
| Flecainide Acetate | 51 | $3,401 | $67 |
| Isosorbide Dinitrate | 32 | $3,133 | $98 |
| Potassium Chloride | 109 | $2,556 | $23 |
| Isosorbide Mononitrate Er | 93 | $2,487 | $27 |
| Clopidogrel | 111 | $2,422 | $22 |
| Furosemide | 276 | $2,399 | $9 |
| Amlodipine Besylate | 342 | $2,366 | $7 |
| Nifedipine Er | 17 | $1,998 | $118 |
| Metoprolol | 149 | $1,477 | $10 |
| Lisinopril | 167 | $1,425 | $9 |
| Pantoprazole | 53 | $1,285 | $24 |
| Hydralazine | 60 | $1,026 | $17 |
| Torsemide | 16 | $946 | $59 |
| Nitroglycerin | 48 | $891 | $19 |
| Diltiazem 24hr Er (Xr) | 12 | $799 | $67 |
| Atenolol | 56 | $798 | $14 |
| Mirtazapine | 11 | $695 | $63 |
| Pravastatin | 34 | $662 | $19 |
| Spironolactone | 53 | $634 | $12 |
| Warfarin | 14 | $541 | $39 |
| Diltiazem 24hr Er | 13 | $524 | $40 |
| Hydrochlorothiazide | 82 | $485 | $6 |
| Benazepril | 36 | $463 | $13 |
| Doxazosin Mesylate | 35 | $433 | $12 |
| Amiodarone | 20 | $404 | $20 |
| Enalapril Maleate | 11 | $347 | $32 |
| Omeprazole | 17 | $294 | $17 |
| Losartan-Hydrochlorothiazide | 20 | $289 | $14 |
| Lisinopril-Hydrochlorothiazide | 13 | $255 | $20 |
| Simvastatin | 35 | $254 | $7 |
| Triamterene-Hydrochlorothiazid | 14 | $181 | $13 |
2021: 48 drugs
| Eliquis | 460 | $624,303 | $1,357 |
| Xarelto | 62 | $83,809 | $1,352 |
| Repatha Sureclick | 103 | $73,926 | $718 |
| Entresto | 15 | $22,681 | $1,512 |
| Metoprolol | 526 | $14,664 | $28 |
| Rosuvastatin | 337 | $13,493 | $40 |
| Diltiazem 24hr Er (Cd) | 170 | $11,350 | $67 |
| Ezetimibe | 107 | $10,672 | $100 |
| Bumetanide | 66 | $9,301 | $141 |
| Atorvastatin | 663 | $8,588 | $13 |
| Praluent | 11 | $5,303 | $482 |
| Valsartan | 53 | $4,333 | $82 |
| Losartan | 259 | $4,315 | $17 |
| Isosorbide Dinitrate | 24 | $3,537 | $147 |
| Digoxin | 86 | $3,297 | $38 |
| Carvedilol | 193 | $3,273 | $17 |
| Clonidine | 13 | $3,078 | $237 |
| Amlodipine Besylate | 331 | $2,845 | $9 |
| Potassium Chloride | 104 | $2,705 | $26 |
| Furosemide | 296 | $2,596 | $9 |
| Flecainide Acetate | 34 | $2,571 | $76 |
| Isosorbide Mononitrate Er | 95 | $2,537 | $27 |
| Nifedipine Er | 23 | $2,233 | $97 |
| Clopidogrel | 112 | $1,679 | $15 |
| Lisinopril | 179 | $1,544 | $9 |
| Dilt-Xr | 18 | $1,457 | $81 |
| Metoprolol | 153 | $1,428 | $9 |
| Ranolazine Er | 12 | $1,381 | $115 |
| Nitroglycerin | 68 | $1,267 | $19 |
| Doxazosin Mesylate | 49 | $1,146 | $23 |
| Pantoprazole | 51 | $1,109 | $22 |
| Cartia Xt | 18 | $985 | $55 |
| Torsemide | 22 | $870 | $40 |
| Spironolactone | 71 | $837 | $12 |
| Hydralazine | 38 | $789 | $21 |
| Warfarin | 19 | $778 | $41 |
| Pravastatin | 44 | $742 | $17 |
| Amiodarone | 28 | $731 | $26 |
| Atenolol | 51 | $684 | $13 |
| Hydrochlorothiazide | 76 | $675 | $9 |
| Losartan-Hydrochlorothiazide | 14 | $511 | $37 |
| Diltiazem 24hr Er | 15 | $470 | $31 |
| Benazepril | 45 | $457 | $10 |
| Simvastatin | 39 | $350 | $9 |
| Triamterene-Hydrochlorothiazid | 15 | $274 | $18 |
| Enalapril Maleate | 12 | $227 | $19 |
| Lisinopril-Hydrochlorothiazide | 14 | $80 | $6 |
| Amoxicillin | 15 | $38 | $3 |
2020: 48 drugs
| Eliquis | 417 | $504,530 | $1,210 |
| Xarelto | 55 | $71,889 | $1,307 |
| Repatha Sureclick | 81 | $43,322 | $535 |
| Metoprolol | 433 | $15,063 | $35 |
| Rosuvastatin | 278 | $14,803 | $53 |
| Atorvastatin | 607 | $9,995 | $16 |
| Diltiazem 24hr Er (Cd) | 143 | $9,215 | $64 |
| Bumetanide | 46 | $8,392 | $182 |
| Ezetimibe | 83 | $7,787 | $94 |
| Entresto | 13 | $7,119 | $548 |
| Valsartan | 48 | $4,710 | $98 |
| Ranolazine Er | 13 | $4,138 | $318 |
| Flecainide Acetate | 40 | $4,098 | $102 |
| Isosorbide Mononitrate Er | 115 | $3,879 | $34 |
| Losartan | 234 | $3,642 | $16 |
| Digoxin | 69 | $3,167 | $46 |
| Carvedilol | 187 | $2,956 | $16 |
| Amlodipine Besylate | 318 | $2,590 | $8 |
| Isosorbide Dinitrate | 19 | $2,524 | $133 |
| Clonidine | 14 | $2,311 | $165 |
| Furosemide | 233 | $1,959 | $8 |
| Potassium Chloride | 71 | $1,935 | $27 |
| Cartia Xt | 32 | $1,822 | $57 |
| Clopidogrel | 117 | $1,758 | $15 |
| Nifedipine Er | 19 | $1,513 | $80 |
| Lisinopril | 172 | $1,480 | $9 |
| Metoprolol | 141 | $1,334 | $9 |
| Torsemide | 30 | $1,329 | $44 |
| Enalapril Maleate | 17 | $1,297 | $76 |
| Losartan-Hydrochlorothiazide | 17 | $1,189 | $70 |
| Nitroglycerin | 44 | $1,074 | $24 |
| Pravastatin | 37 | $1,038 | $28 |
| Dilt-Xr | 15 | $1,011 | $67 |
| Pantoprazole | 49 | $993 | $20 |
| Doxazosin Mesylate | 30 | $942 | $31 |
| Atenolol | 51 | $922 | $18 |
| Warfarin | 22 | $860 | $39 |
| Labetalol | 11 | $801 | $73 |
| Spironolactone | 75 | $715 | $10 |
| Hydralazine | 27 | $692 | $26 |
| Amiodarone | 32 | $639 | $20 |
| Hydrochlorothiazide | 83 | $609 | $7 |
| Benazepril | 34 | $413 | $12 |
| Clonidine | 19 | $392 | $21 |
| Simvastatin | 38 | $380 | $10 |
| Triamterene-Hydrochlorothiazid | 23 | $318 | $14 |
| Diltiazem 24hr Er | 12 | $294 | $25 |
| Lisinopril-Hydrochlorothiazide | 16 | $225 | $14 |
2019: 44 drugs
| Eliquis | 370 | $396,090 | $1,071 |
| Xarelto | 65 | $71,328 | $1,097 |
| Repatha Sureclick | 58 | $65,048 | $1,122 |
| Metoprolol | 371 | $14,888 | $40 |
| Rosuvastatin | 198 | $12,598 | $64 |
| Atorvastatin | 601 | $11,320 | $19 |
| Diltiazem 24hr Er (Cd) | 124 | $8,585 | $69 |
| Ezetimibe | 55 | $4,806 | $87 |
| Flecainide Acetate | 52 | $4,043 | $78 |
| Bumetanide | 21 | $3,728 | $178 |
| Carvedilol | 180 | $2,872 | $16 |
| Digoxin | 56 | $2,761 | $49 |
| Losartan | 200 | $2,733 | $14 |
| Furosemide | 243 | $2,652 | $11 |
| Valsartan | 38 | $2,622 | $69 |
| Amlodipine Besylate | 218 | $2,240 | $10 |
| Potassium Chloride | 55 | $2,174 | $40 |
| Isosorbide Mononitrate Er | 80 | $2,100 | $26 |
| Enalapril Maleate | 21 | $1,733 | $83 |
| Isosorbide Dinitrate | 18 | $1,695 | $94 |
| Lisinopril | 164 | $1,611 | $10 |
| Clopidogrel | 70 | $1,363 | $19 |
| Toprol Xl | 20 | $1,342 | $67 |
| Cartia Xt | 21 | $1,307 | $62 |
| Pravastatin | 48 | $1,199 | $25 |
| Verapamil Er | 15 | $1,152 | $77 |
| Metoprolol | 105 | $1,108 | $11 |
| Hydralazine | 32 | $942 | $29 |
| Nitroglycerin | 46 | $849 | $18 |
| Pantoprazole | 33 | $773 | $23 |
| Dilt-Xr | 11 | $767 | $70 |
| Torsemide | 24 | $698 | $29 |
| Spironolactone | 59 | $689 | $12 |
| Amiodarone | 28 | $621 | $22 |
| Hydrochlorothiazide | 79 | $606 | $8 |
| Simvastatin | 48 | $589 | $12 |
| Warfarin | 21 | $535 | $25 |
| Irbesartan | 12 | $498 | $41 |
| Benazepril | 27 | $402 | $15 |
| Atenolol | 22 | $362 | $16 |
| Losartan-Hydrochlorothiazide | 21 | $304 | $14 |
| Triamterene-Hydrochlorothiazid | 13 | $213 | $16 |
| Clonidine | 11 | $179 | $16 |
| Lisinopril-Hydrochlorothiazide | 13 | $150 | $12 |
2018: 45 drugs
| Eliquis | 327 | $318,887 | $975 |
| Xarelto | 69 | $62,777 | $910 |
| Repatha Sureclick | 42 | $46,331 | $1,103 |
| Metoprolol | 374 | $14,369 | $38 |
| Atorvastatin | 573 | $12,734 | $22 |
| Rosuvastatin | 97 | $6,625 | $68 |
| Diltiazem 24hr Er (Cd) | 89 | $4,772 | $54 |
| Flecainide Acetate | 50 | $4,767 | $95 |
| Ezetimibe | 35 | $4,437 | $127 |
| Cartia Xt | 61 | $3,366 | $55 |
| Bumetanide | 19 | $2,807 | $148 |
| Losartan | 215 | $2,432 | $11 |
| Clonidine | 16 | $2,171 | $136 |
| Isosorbide Mononitrate Er | 61 | $2,136 | $35 |
| Digoxin | 35 | $2,128 | $61 |
| Valsartan | 42 | $2,005 | $48 |
| Furosemide | 229 | $1,807 | $8 |
| Carvedilol | 153 | $1,797 | $12 |
| Digox | 27 | $1,712 | $63 |
| Potassium Chloride | 42 | $1,625 | $39 |
| Amlodipine Besylate | 167 | $1,517 | $9 |
| Pravastatin | 45 | $1,387 | $31 |
| Verapamil Er | 13 | $1,172 | $90 |
| Enalapril Maleate | 17 | $1,083 | $64 |
| Toprol Xl | 13 | $1,075 | $83 |
| Metoprolol | 102 | $1,014 | $10 |
| Lisinopril | 151 | $1,003 | $7 |
| Warfarin | 41 | $964 | $24 |
| Hydralazine | 35 | $888 | $25 |
| Clopidogrel | 47 | $801 | $17 |
| Dilt-Xr | 12 | $771 | $64 |
| Nitroglycerin | 35 | $713 | $20 |
| Torsemide | 19 | $640 | $34 |
| Simvastatin | 52 | $638 | $12 |
| Spironolactone | 54 | $600 | $11 |
| Nifedipine Er | 11 | $537 | $49 |
| Amiodarone | 29 | $498 | $17 |
| Irbesartan | 17 | $390 | $23 |
| Pantoprazole | 18 | $384 | $21 |
| Hydrochlorothiazide | 52 | $366 | $7 |
| Atenolol | 24 | $299 | $12 |
| Labetalol | 12 | $293 | $24 |
| Benazepril | 24 | $266 | $11 |
| Ranitidine | 12 | $212 | $18 |
| Losartan-Hydrochlorothiazide | 14 | $198 | $14 |
2017: 39 drugs
| Eliquis | 222 | $209,609 | $944 |
| Xarelto | 68 | $63,046 | $927 |
| Repatha Sureclick | 19 | $22,289 | $1,173 |
| Metoprolol | 320 | $12,882 | $40 |
| Atorvastatin | 487 | $10,571 | $22 |
| Crestor | 14 | $10,352 | $739 |
| Ranexa | 11 | $6,684 | $608 |
| Flecainide Acetate | 80 | $6,395 | $80 |
| Rosuvastatin | 42 | $4,527 | $108 |
| Ezetimibe | 11 | $4,007 | $364 |
| Cartia Xt | 63 | $2,831 | $45 |
| Diltiazem 24hr Er | 60 | $2,779 | $46 |
| Isosorbide Mononitrate Er | 90 | $2,707 | $30 |
| Losartan | 184 | $2,110 | $11 |
| Carvedilol | 174 | $2,081 | $12 |
| Isosorbide Dinitrate | 12 | $2,080 | $173 |
| Potassium Chloride | 51 | $2,000 | $39 |
| Valsartan | 34 | $1,937 | $57 |
| Digoxin | 26 | $1,855 | $71 |
| Bumetanide | 15 | $1,660 | $111 |
| Pravastatin | 61 | $1,649 | $27 |
| Digox | 19 | $1,544 | $81 |
| Furosemide | 199 | $1,428 | $7 |
| Amlodipine Besylate | 171 | $1,350 | $8 |
| Lisinopril | 170 | $1,230 | $7 |
| Verapamil Er | 16 | $1,100 | $69 |
| Nitroglycerin | 34 | $903 | $27 |
| Warfarin | 34 | $801 | $24 |
| Hydralazine | 31 | $787 | $25 |
| Dilt-Xr | 15 | $777 | $52 |
| Metoprolol | 103 | $766 | $7 |
| Clopidogrel | 33 | $684 | $21 |
| Spironolactone | 56 | $576 | $10 |
| Simvastatin | 62 | $514 | $8 |
| Atenolol | 48 | $507 | $11 |
| Pantoprazole | 18 | $330 | $18 |
| Ranitidine | 18 | $266 | $15 |
| Hydrochlorothiazide | 37 | $217 | $6 |
| Benazepril | 20 | $216 | $11 |
2016: 37 drugs
| Eliquis | 204 | $158,557 | $777 |
| Xarelto | 56 | $48,135 | $860 |
| Metoprolol | 301 | $11,980 | $40 |
| Atorvastatin | 413 | $9,616 | $23 |
| Crestor | 17 | $9,420 | $554 |
| Ranexa | 14 | $5,696 | $407 |
| Diltiazem 24hr Er | 56 | $2,911 | $52 |
| Flecainide Acetate | 67 | $2,723 | $41 |
| Valsartan | 23 | $2,476 | $108 |
| Plavix | 12 | $2,353 | $196 |
| Isosorbide Mononitrate Er | 86 | $2,194 | $26 |
| Carvedilol | 171 | $1,911 | $11 |
| Cartia Xt | 44 | $1,872 | $43 |
| Rosuvastatin | 14 | $1,696 | $121 |
| Losartan | 142 | $1,682 | $12 |
| Digoxin | 31 | $1,627 | $52 |
| Lisinopril | 173 | $1,622 | $9 |
| Potassium Chloride | 47 | $1,604 | $34 |
| Amlodipine Besylate | 136 | $1,413 | $10 |
| Pravastatin | 46 | $1,247 | $27 |
| Furosemide | 161 | $1,125 | $7 |
| Warfarin | 44 | $1,038 | $24 |
| Clopidogrel | 45 | $1,032 | $23 |
| Nitrostat | 37 | $865 | $23 |
| Simvastatin | 69 | $802 | $12 |
| Metoprolol | 86 | $659 | $8 |
| Hydralazine | 21 | $595 | $28 |
| Verapamil Er | 18 | $552 | $31 |
| Atenolol | 42 | $477 | $11 |
| Spironolactone | 43 | $448 | $10 |
| Nitroglycerin | 15 | $331 | $22 |
| Pantoprazole | 13 | $293 | $23 |
| Irbesartan | 11 | $289 | $26 |
| Hydrochlorothiazide | 31 | $216 | $7 |
| Losartan-Hydrochlorothiazide | 13 | $170 | $13 |
| Ranitidine | 12 | $168 | $14 |
| Benazepril | 11 | $132 | $12 |
2015: 37 drugs
| Xarelto | 102 | $78,501 | $770 |
| Eliquis | 62 | $39,774 | $642 |
| Crestor | 28 | $13,896 | $496 |
| Metoprolol | 233 | $10,507 | $45 |
| Atorvastatin | 368 | $8,766 | $24 |
| Flecainide Acetate | 51 | $2,776 | $54 |
| Valsartan | 11 | $2,769 | $252 |
| Digoxin | 36 | $2,449 | $68 |
| Digox | 29 | $2,077 | $72 |
| Diltiazem 24hr Er | 45 | $1,986 | $44 |
| Pravastatin | 55 | $1,860 | $34 |
| Isosorbide Mononitrate Er | 60 | $1,666 | $28 |
| Carvedilol | 152 | $1,569 | $10 |
| Cartia Xt | 30 | $1,423 | $47 |
| Lisinopril | 166 | $1,406 | $8 |
| Losartan | 118 | $1,249 | $11 |
| Warfarin | 36 | $1,174 | $33 |
| Metoprolol | 84 | $995 | $12 |
| Clopidogrel | 64 | $966 | $15 |
| Furosemide | 157 | $938 | $6 |
| Diltiazem Er | 20 | $928 | $46 |
| Amlodipine Besylate | 95 | $927 | $10 |
| Simvastatin | 97 | $908 | $9 |
| Potassium Chloride | 19 | $730 | $38 |
| Diltiazem 24hr Cd | 15 | $692 | $46 |
| Nitrostat | 35 | $639 | $18 |
| Hydralazine | 25 | $558 | $22 |
| Atenolol | 47 | $529 | $11 |
| Pantoprazole | 27 | $361 | $13 |
| Spironolactone | 44 | $352 | $8 |
| Irbesartan | 11 | $315 | $29 |
| Hydrochlorothiazide | 37 | $306 | $8 |
| Amiodarone | 11 | $272 | $25 |
| Verapamil Er | 12 | $231 | $19 |
| Benazepril | 12 | $217 | $18 |
| Triamterene-Hydrochlorothiazid | 12 | $180 | $15 |
| Ranitidine | 14 | $159 | $11 |
2014: 39 drugs
| Xarelto | 105 | $55,007 | $524 |
| Crestor | 31 | $14,403 | $465 |
| Atorvastatin | 307 | $10,537 | $34 |
| Metoprolol | 196 | $10,310 | $53 |
| Diovan | 14 | $6,431 | $459 |
| Pradaxa | 14 | $5,293 | $378 |
| Carvedilol | 164 | $2,498 | $15 |
| Flecainide Acetate | 46 | $2,285 | $50 |
| Clopidogrel | 82 | $2,200 | $27 |
| Digoxin | 30 | $2,197 | $73 |
| Digox | 25 | $2,021 | $81 |
| Diltiazem 24hr Er | 34 | $1,795 | $53 |
| Lisinopril | 176 | $1,791 | $10 |
| Isosorbide Mononitrate Er | 67 | $1,579 | $24 |
| Losartan | 84 | $1,306 | $16 |
| Pravastatin | 31 | $1,261 | $41 |
| Simvastatin | 82 | $1,046 | $13 |
| Diltiazem Er | 21 | $1,007 | $48 |
| Warfarin | 52 | $985 | $19 |
| Cartia Xt | 19 | $891 | $47 |
| Hydralazine | 19 | $793 | $42 |
| Furosemide | 141 | $766 | $5 |
| Potassium Chloride | 18 | $756 | $42 |
| Metoprolol | 73 | $739 | $10 |
| Amlodipine Besylate | 65 | $700 | $11 |
| Atenolol | 55 | $625 | $11 |
| Diltiazem 24hr Cd | 12 | $605 | $50 |
| Nitrostat | 31 | $468 | $15 |
| Verapamil Er | 13 | $463 | $36 |
| Losartan-Hydrochlorothiazide | 15 | $422 | $28 |
| Pantoprazole | 33 | $405 | $12 |
| Spironolactone | 48 | $374 | $8 |
| Bumetanide | 13 | $324 | $25 |
| Lovastatin | 16 | $269 | $17 |
| Hydrochlorothiazide | 32 | $254 | $8 |
| Ranitidine | 12 | $219 | $18 |
| Triamterene-Hydrochlorothiazid | 12 | $176 | $15 |
| Clonidine | 14 | $112 | $8 |
| Allopurinol | 12 | $59 | $5 |
2013: 32 drugs
| Crestor | 47 | $18,873 | $402 |
| Xarelto | 42 | $16,338 | $389 |
| Atorvastatin | 186 | $9,262 | $50 |
| Metoprolol | 154 | $7,947 | $52 |
| Pradaxa | 16 | $6,925 | $433 |
| Diovan | 17 | $4,297 | $253 |
| Clopidogrel | 86 | $4,283 | $50 |
| Flecainide Acetate | 38 | $2,883 | $76 |
| Carvedilol | 166 | $2,699 | $16 |
| Isosorbide Mononitrate Er | 66 | $1,714 | $26 |
| Diltiazem 24hr Er | 43 | $1,664 | $39 |
| Lisinopril | 152 | $1,613 | $11 |
| Simvastatin | 106 | $1,562 | $15 |
| Losartan | 59 | $1,465 | $25 |
| Warfarin | 74 | $1,195 | $16 |
| Metoprolol | 74 | $969 | $13 |
| Diltiazem 24hr Cd | 19 | $919 | $48 |
| Diltiazem Er | 14 | $849 | $61 |
| Furosemide | 131 | $778 | $6 |
| Amlodipine Besylate | 58 | $675 | $12 |
| Pravastatin | 19 | $644 | $34 |
| Digox | 25 | $542 | $22 |
| Verapamil Er | 11 | $466 | $42 |
| Potassium Chloride | 15 | $436 | $29 |
| Hydrochlorothiazide | 25 | $341 | $14 |
| Atenolol | 45 | $339 | $8 |
| Spironolactone | 37 | $314 | $8 |
| Omeprazole | 12 | $295 | $25 |
| Benazepril | 13 | $234 | $18 |
| Nitrostat | 16 | $207 | $13 |
| Pantoprazole | 14 | $200 | $14 |
| Digoxin | 11 | $191 | $17 |
Money from drug and device companies
$15,790 in 2025
| 2025 | 5 | 22 | $14,500 | $15,790 |
| 2024 | 6 | 19 | $10,500 | $12,694 |
| 2023 | 5 | 23 | None | $2,036 |
| 2022 | 1 | 1 | None | $144 |
| 2021 | 3 | 5 | None | $303 |
| 2020 | 1 | 10 | None | $1,053 |
| 2019 | 4 | 17 | None | $1,985 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Mitraclip | $14,723 | 12 payments
|
| Edwards Lifesciences | Evoque | $671 | 6 payments
|
| Heartflow | Ffrct | $198 | 2 payments
|
| Medtronic | Corevalve Evolut R | $133 | 1 payment
|
| Boston Scientific | Watchman Flx | $65 | 1 payment
|
See all 22 published payments
| Abbott Laboratories | Consulting · 2025-12-18 | Mitraclip | $4,500 |
| Abbott Laboratories | Travel · 2025-12-18 | Mitraclip | $6 |
| Abbott Laboratories | Meals · 2025-12-11 | Mitraclip | $19 |
| Medtronic | Meals · 2025-10-28 | Corevalve Evolut R | $133 |
| Boston Scientific | Meals · 2025-10-26 | Watchman Flx | $65 |
| Abbott Laboratories | Consulting · 2025-09-30 | Mitraclip | $4,500 |
| Abbott Laboratories | Travel · 2025-09-30 | Mitraclip | $6 |
| Abbott Laboratories | Travel · 2025-09-30 | Mitraclip | $9 |
| Abbott Laboratories | Meals · 2025-09-09 | Triclip | $24 |
| Abbott Laboratories | Consulting · 2025-07-08 | Mitraclip | $2,000 |
| Abbott Laboratories | Consulting · 2025-07-08 | Mitraclip | $500 |
| Abbott Laboratories | Consulting · 2025-04-01 | Triclip | $3,000 |
| Heartflow | Meals · 2025-03-19 | Ffrct | $167 |
| Abbott Laboratories | Meals · 2025-02-24 | Mitraclip | $22 |
| Abbott Laboratories | Meals · 2025-02-24 | Mitraclip | $137 |
| Heartflow | Meals · 2025-02-18 | Ffrct | $31 |
| Edwards Lifesciences | Travel · 2025-02-05 | Evoque | $260 |
| Edwards Lifesciences | Travel · 2025-01-23 | Evoque | $168 |
| Edwards Lifesciences | Meals · 2025-01-14 | None | $34 |
| Edwards Lifesciences | Meals · 2025-01-14 | None | $7 |
| Edwards Lifesciences | Meals · 2025-01-14 | None | $24 |
| Edwards Lifesciences | Travel · 2025-01-10 | Evoque | $176 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $12,694
| Abbott Laboratories | Mitraclip | $11,815 | 13 payments
|
| Edwards Lifesciences | Evoque | $470 | 1 payment
|
| Heartflow | Ffrct | $162 | 1 payment
|
| Medtronic | Corevalve Evolut R | $157 | 1 payment
|
| Boston Scientific | Watchman Access System | $65 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $25 | 1 payment
|
2023: $2,036
| Medtronic | None | $1,264 | 11 payments
|
| Boston Scientific | Watchman Flx | $356 | 4 payments
|
| Abbott Laboratories | Mitraclip | $282 | 5 payments
|
| HeartFlow | Ffrct | $94 | 1 payment
|
| Penumbra | Penumbra System | $40 | 2 payments
|
2022: $144
| Abbott Laboratories | None | $144 | 1 payment
|
2021: $303
| Abbott Laboratories | Mitraclip System | $172 | 3 payments
|
| Boston Scientific | Choice | $115 | 1 payment
|
| HeartFlow | Ffrct | $16 | 1 payment
|
2020: $1,053
| Abbott Laboratories | Mitra Clip System | $1,053 | 10 payments
|
2019: $1,985
| Abbott Laboratories | Mitra Clip System | $1,377 | 8 payments
|
| Edwards Lifesciences | None | $419 | 6 payments
|
| Medtronic Vascular | 3f | $172 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $17 | 1 payment
|
Professional record
- NPI
- 1437329562
- Licence
- CA A82854California A82854: Current · expires 2028-06-30
- Trained
- Washington University School of Medicine, 2001
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2008-03-05
- NPI last updated
- 2011-12-09
This is when the NPI record was last certified, not a medical board exam.